Also trades as: MRMD.CN (CNQ) · $vol 0M
MRMD OTC
MariMed Inc.
1W: -10.4%
1M: -11.0%
3M: +1.9%
YTD: -23.3%
1Y: -57.1%
3Y: -84.2%
5Y: -92.8%
$0.07
-0.00 (-0.86%)
Weekly Expected Move ±7.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-04-01
Earliest Filing
2026-03-02
Latest Filing
investor: 4
target: 2
customer: 2
partner: 1
Counterparties (Filed by MRMD)
9 relationshipsCompanies named in MRMD's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Navy Capital Green International, Ltd. | — | investor | Original investor in private placement financing and holder of Series B Preferred Stock prior to restructuring. | 2026-03-02 | View |
| Navy Capital Green Fund, LP | — | investor | Lender and recipient of new promissory notes and New Series B Preferred Stock. | 2026-03-02 | View |
| Navy Capital Green Co-Invest Fund, LLC | — | investor | Lender and recipient of new promissory notes and New Series B Preferred Stock. | 2026-03-02 | View |
| Navy Capital Green Holdings II, LLC | — | investor | Lender and recipient of new promissory notes and New Series B Preferred Stock. | 2026-03-02 | View |
| Navy Capital Green Management, LLC | — | partner | Discretionary investment manager for the Navy Capital Green funds involved in the restructuring. | 2026-03-02 | View |
| Ermont, Inc. | — | target | Target of a prior asset acquisition for which a note was issued. | 2023-11-20 | View |
| Kind Therapeutics USA, LLC | — | target | MariMed Inc. agreed to acquire this Maryland licensed vertically integrated cannabis business. | 2022-01-05 | View |
| MariMed, Inc. | MRMD | customer | Borrower in the amended promissory note agreement | 2021-04-01 | View |
| MariMed Hemp, Inc. | MRMD | customer | Co-borrower in the amended promissory note agreement | 2021-04-01 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Other Events; Exhibits | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-06-08 | Shareholder Vote | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-03-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-02 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-13 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-03-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-20 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
| 2023-11-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-08-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR